SYNA SYNAPTICS Inc Insider Trading

Esther Song sells 8,833 shares of SYNA across 6 transactions for $1.2M under 10b5-1 plan.

Esther Song executed six separate sales totaling 8,833 shares for $1,246,958.82 at blended average price $141.17 under a pre-arranged 10b5-1 trading plan, reducing her holdings from 21,254 shares to 12,421 shares (a -41.6% reduction in position size). This is a scheduled transaction, not a discretionary trade. The company posted net income of $-8,000,000.00 in its latest fiscal year while generating revenue of $294,200,000.00, with annual revenue growth of +12.0% and a market cap of $5,304,181,396.80. The stock has appreciated +55.0% over the past 30 days and +68.5% over 90 days, though it trades -7.9% below its 52-week high of $149.11. The magnitude of the position reduction and the unprofitable operating context merit attention, but the 10b5-1 plan nature removes timing signals.

Ganesan Satish sold 18,285 shares at $80.02–$80.67 for $1,468,127.80 (-18.7% of holdings)

Ganesan Satish executed 2 separate sales totaling 18,285 shares for $1,468,127.80 at blended average price $80.29, reducing his holdings by 18.7% from 97,636 to 79,351 shares. The transaction prices of $80.02–$80.67 represent a $2.86–$3.24 premium to the current price of $77.43, placing the trades within a 52-week range ($42.92–$87.87) at approximately 11.9% below the high. SYNA is currently unprofitable with full-year net income of $-20,600,000.00 despite quarterly revenue of $292,500,000.00 and annual revenue growth of 12.0%. The sale size and price context warrant monitoring as context for broader capital allocation signaling, though the filing alone does not identify a scheduled trading plan or explicit motive.

Rizvi Ken purchased 3,600 shares of SYNA at $69.15; holdings now 27,630 shares (+15.0%)

Rizvi Ken acquired 3,600 shares of Synaptics at $69.15, expanding his holdings by 15.0% to 27,630 shares. The transaction occurs at a price 1.4% above the current market price of $68.22, within the 52-week range of $68.09–$113.68, and notably 40.0% below the 52-week high. Across all tickers, Rizvi has a track record of 1 prior buy with average 90-day returns of +68.7% and a 100.00% win rate, suggesting a history of well-timed entry points. Synaptics faces material headwinds, with annual revenue declining -29.2% year-over-year and net income compressed to $1.8M on $267.2M quarterly revenue, yet the insider chose to increase exposure during the recent -10.2% 30-day and -8.4% 90-day pulldowns.